Ryan F. Quarles: “Similarly, that has always been a high priority of the Federal Reserve, and where we have the enforcement authority to…”

I do think that a legislature is in a better position to resist the slippery slope for that solution.

The FDA needs to provide regulatory pathways for products containing CBD. The FDA needs to act now.

I do think that certainly, the way that we have implemented the Volcker Rule... it has been excessively burdensome.

The Federal Reserve, along with the other U.S. banking agencies, has made substantial progress in building stronger regulatory and supervisory programs since the global financial crisis.